The role of peroxisome proliferator activated receptor α in peroxisome proliferation, physiological homeostasis, and chemical carcinogenesis

Advances in Experimental Medicine and Biology

Volumn 422, Issue , 1997, Pages 109-125

  Gonzalez, Frank J ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; CELL SURFACE RECEPTOR; CLOFIBRATE; ETOFIBRATE; FENOFIBRATE; GEMFIBROZIL; HERBICIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PEROXISOME PROLIFERATOR; PESTICIDE; PHTHALIC ACID;

ARTICLE; CANCER RISK; CELL INTERACTION; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; ENZYME ACTIVITY; GROWTH REGULATION; HUMAN; LIVER CARCINOGENESIS; LIVER CARCINOMA; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SIGNAL TRANSDUCTION;

EID: 0030669636     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-2670-1_9     Document Type: Article

References (110)

1. Reddy, J.K. and Mannaerts, G.P. Peroxisomal lipid metabolism. Annu. Rev. Nulr., 14: 343-370, 1994.
2. Wanders, R.J., Schutgens, R.B., and Barth, P.G. Pcroxisomal disorders: a review. J. Neuropathol. Exp. Neurol., 54: 726-739, 1945.
3. Wanders, R.J., Barth, P.G., Sehutgens, R.B., and Tager, J.M. Clinical and biochemical characteristics of peroxisomal disorders: an update. Eur. J. Pediatr., 153: S44-S48, 1994.
4. Reddy, J.K., Goel, S.K., Nemali, M.R., Carrino, J.J., Laffler, T.G., Reddy, M.K., Sperbeck, S.J., Osumi. T., Hashimoto, T., and Lalwani. N.D. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome prohferators. Proc. Natl. Acncl. Sci. USA., 83: 1747-1751, 1986.
5. Kimura, S., Hardwick, J.P., Kozak, C.A., and Gonzalez, K.J. The rat clofibrate-inducihle CYP4A subfamily. II. cDNA sequence of IVA3. mapping of the Cyp4a locus to mouse chromosome 4. and coordinate and tissue-specific regulation of the C'YIMA genes. DNA, 8: 517-525. 1989.
6. Kimura, S., Hanioku. N., Matsunaga. F.,. and Gonzalez, F.J. The rat clofibrate-mducible C'YIMA gene subfamily. I. Complete intron and exon sequence of the CYP4AI and CYP4A2 genes, unique exon organi/ation. and identification of a conserved 19-bp upstream element. DNA. 8: 503-516. 1989.
7. Issemann. I., Prince, R.A., Tugvvood, I.D., and Green, S. The peroxisome proliferator-activated receptor: retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. Mol. Hndocrinol., II: 37-47. 1993.
8. Green. S. PPAR: a mediator of peroxisome proliterator action. Mutat. Res., 333: 101 -109. 1995.
9. Gottlicher. M., Widmark, F., Li, Q., and Gustafsson, J.A. Fatty acids activate a chimera of ihe clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sei. USA., 89: 4653-4657, 1992.
10. Dreyer. C., Krey. G., Keller. H., Givel, F., Helftenbein. G., and Wahli. W. Control of the peroxisomal betaoxidation pathway by a novel family of nuclear hormone receptors. Cell, 68: 879-887. 1992.
11. Zhu. Y., Alvares, K., Huang, Q., Rao, M.S., and Reddy, J.K. Cloning of a new member of the peroxisome proliferator-aetivated receptor gene family from mouse liver. J. Biol. C'hem., 268: 26817-26820. 1993.
12. Zhu. Y., Qi. C'., Korenberg, J.R., C'hen, X.N., Noya. D., Rao, M.S., and Reddy. J.K. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc. Natl. Acad. Sei. USA., 92: 7921-7925, 1995.
13. Tontonoz, P., Hu. E., Graves, R.A., Budavari, A.I., and Spiegelman, B.M. mPPARgamma2: tissue-specific regulator ur'an adipocyte enhancer. Genes. Dev., 8: (224-1234. 1994.
14. Chen. F., Law, S.W., and O'Malley, B.W. Identification of two mPPAR related receptors and evidence fur the existence of five subfamily members. Biochem. Biophys. Res. Commun., 196: 671-677. 1993.
15. Kliewer, S.A., Forman, B.M., Blumberg. B., Ong, E.S., Borgmeyer. U., Mangelsdorf. D.I. Umesono. K., and Evans. R.M. Differential expression and activation of a family of muri ne peroxisome proliferator-activaled receptors. Proc. Nat I. Acad. Sci. USA., 91: 7355-7359, 1994.
16. Jow, L. and Mukherjee. R. The human peroxisome proliferator-activated receptor (PPAR) subtype NUCI represses the activation of h PPAR alpha and thyroid hormone receptors. J. Biol. (Them., 270: 3X36-3X40. 1995.
17. Amri, E.Z., Bonino. F., Ailhaud. G., Ahumrad, N.A., and Grimaldi. P.A. Cloning of a protein that mediates transcriplional effects of fatty acids in prcadipocytes. Homology to peroxisome proliferator-activated receptors. J. Biol. Chem., 270: 2367-2371, 1995.
18. Lemberger, T., Staels, B., Saladin, R., Desvergne. B., Auwerx. J., and Wahli. W. Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. J. Biol. Chem., 269: 24527-24531, 1994.
19. Braissant, O., Foufelle, F., Scotto, C., Dauca, M., and Wahli, W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha. -beta, and -gamma in the adult rat. Endocrinology. 137: 354-366, 1996.
20. Tontonoz, P., Hu. E., and Spiegelman. B.M. Stimulation of adipogcnesis in fibroblasts by PPAR gamma 2. a lipid-activatcd transcription factor [published erratum appears in Cell 1995 Mar 24:XO(6):following 957], Cell. 79: 1147-1156, 1994.
21. Tontono. P., Hu. E., and Spiegelman, B.M. Regulation of adipocyte gene expression and differentiation by peroxisome prolifcrator activated receptor gamma. Curr. Opin. Genet. Dev., 5: 571-576. 1995.
22. Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M., and Kliewer. S.A. An antidiabctic thiazolidincdionc is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem., 270: 12953-12956. 1995.
23. Goeckc-Flora, C.M., Wyman, J.F., Jarnot, B.M., and Reo, N.V. Effect of the peroxisome prolifcrator perfluoro-n-decanoic acid on glucose transport in the isolated perfused rat liver. Chem. Res. Toxicol., X: 77-81. 1995.
24. Sher, T., Yi, H.F., McBridc, O.W., and Gonzalez. F.J. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliterator activated receptor. Biochemistry. 32: 559X-S604.1993.
25. Muerhot'f, A.S., Griffln, K.J., and Johnson, R. F. The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochromc P450 fatty acid omega-hydroxylase. by clofibric acid. J. Biol. Chem., 267: 19051-19053. 1992.
26. Brandes. R., Kaikaus, R.M., Lyscnko. N., Ockner, R.K., and Bass. N.M. Induction of fatty acid binding protein by peroxisome proliferalors in primary hcpatocyte cultures and its relationship to the induction of peroxisomal beta-oxidation. Biochim. Biophys. Acta. 1034: 53-61. 1990.
27. Gulick. T., Cresci. S., Caira. T., Moore, D.D., and Kelly, D.P The peroxisome prolifcrator-actisated receptor regulates mitochondria! fatty acid oxidative enzyme gene expression. Proc. Natl. Acad. Sei. USA., 91: 11012-11016. 1994.
28. Rodriguez, J.C., Gil-Gomez. G., Hcgardt, F.G., and Haro, D. Peroxisome proliferator-actiated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J. Biol. Chem., 269: 18767-18772, 1994.
29. Castelein, H., Gulick. T., Dcclercq, P.E., Mannaerts, G.P., Moore, D.D., and Baes. M.I. The peroxisome proliferator activated receptor regulates malic enzyme gene expression. J. Biol. Chem., 269: 26754-26758. 1994.
30. Kaikaus, R.M., Chan, W.K., Lysenko. N., Ray. R., Ortiz de Montellano, P.R., and Bass. N.M. Induction of peroxisomal fatty acid beta-oxidation and liver fatty acid-binding protein by peroxisome proliferators. Mediation via the cytochrome P-450IVAI omega-hydroxylase pathway. J. Biol. Chem., 268: 9593-9603. 1993.
31. Demoz. A., Vaagenes. H., Aarsaether, N., Hvattum. E., Skorve. J., Gottlicher. M., Lillehaug. JR., Gibson. G.G., Gustafsson, J.A., and Hood, S. Coordinate induction of hepatic fatty acyl-CoA oxida.se and P4504AI in rat after activation of the peroxisome proliferator-activated receptor (PPAR) by sulphur-substituted fatty acid analogues. Xenobiotica., 24: 943-956. 1994.
32. Berge, R.K., Aars land. A., Kryvi, H., Bremer. J., and Aarsaether. N. Alkyllhioacetic acid (3-thia fatty acids)-a new group of non-beta-oxidizable. peroxisome-inducing fatty acid analogues. I. A study on the structural requirements for proliferation of peroxisomes and mitochondria in rat liver. Biochim. Biophys. Acta. 1004: 345-356, 1989.
33. Kaikaus, R.M., Sui. Z., Lysenko, N., Wu, N.Y., Ortiz de Montellano, P.R., Ockncr, R.K., and Bass. N.M. Regulation of pathways of extramitochondrial fatty acid oxidation and liver fatty acid-binding protein by long-chain monocarboxylic fatly acids in hepatoeytes. Effect of inhibition of camitinc palmitoyltransferase I.J.Biol.Chem., 268:26866-26871, 1993.
34. Aldridge, T.C., Tugwood, J.D., and Green. S. Identification and characterization of ON A elements implicated in the regulation of CYP4A1 transcription. Biochem. J., 306: 473-479. 1995.
35. Kliewer, S.A., Umesono, K., Noonan, D.J., Heyman, R.A., and Evans. K.M. Convergence of 9-cis rctinoic acid and peroxisome prolifcrator signalling pathways through heterodimer formation of their receptors. Nature. 358: 771-774. 1992.
36. Gearing, K.L., Gottlicher, M., Teboul, M., Widmark, E., and Gustafsson, J.A. Interaction of the pcroxisome-proliferator-activated receptor and relinuid X receptor. Proc. Natl. Acad. Sei. USA., 90: 1440-1444. 1993.
37. Huan. B., Kosovsky, M.J., and Siddiqui. A. Relinoid X receptor alpha transactivates the hepatitis B virus enhancer I element by forming a heterodimcric complex with the peroxisome prol iterator-activated receptor. J. Virol., 69: 547-551. 1995.
38. Bogazzi, F., Hudson, L.D., and Nikodem. V.M. A novel heterodiinerization partner for thyroid hormone receptor. Peroxisome prolifcraior-aetivated receptor. J. Biol. C'hem., 269: 11683-11686. 1494.
39. Ladias. J.A. and Karathanasis. S.K. Regulation of the apolipoprotein AI gene by ARP-1. a novel member of the steroid receptor superfamily. Science. 251: 561-565. 1991.
40. Ladias. .I.A., Hadzopoulou-Cladaras, M., Kardassis. D., Cardot, P., Cheng, J., Zannis. V., and Cladarus. C. Transcriptional regulation of human apolipoprotein genes ApoB. ApoCIII. and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-I. EAR-2, and EAR-3. J. Biol. them., 267: 15849-15860. 1992.
41. Palmer, C.N., llsu, M.H., Muerhoti, A.S., Griffin, K.J., and Johnson. E.F. Interaction of the peroxisome proliferator-aclivated receptor alpha with the rctinoid X receptor alpha unmasks a cryptic peroxisome proIiterator response clement that overlaps an ARP-l-binding site in the CYP4A6 promoter. J. Biol. C'hern., 269: 18083-18089. 1994.
42. Winrow, C.J., Marcus, S.L., Miyata, K.S., Zhang. B., Capone, J.P., und Rachubinski. R.A Transactivation of the peroxisome prolifcrator-activatcd receptor is differentially modulated by hepatocytc nuclear factor-4. Gene Expr., 4: 53-62. 1994.
43. Carter, M.F.,. Gulick. T., Raisher, B.D., Caira. T., Ladias, J.A., Moore, D.D., and Kelly. O.P. Hepatocyte nuclear faclor-4 activates medium chain acyl-CoA dehydrogcnase gene transcription hy interacting with a complex regulatory clement. J. Biol. Chcm., 268: 13805- 13810. 1993.
44. Hen. R., Bishara-Shicban. J., and Bar-Tana. J. Mode of action of peroxisome proliterators as hypolipidcmic drugs. Suppression of apolipoprotein C-III. J. Biol. Chcm., 270: 13470-13475. 1995.
45. Staels. B . Van Tol. A., Andreu, T., and Auwerx, J. Fibratcs influence the expression of genes involved in lipoprotcin metabolism in a tissue-selective manner in the rat. Arterioscler. Thromb., 12: 286-294. 1992.
46. Bcrthou. L., Saladin. R . Yaqoob. P., Caldcr. P., Fruchart, J.C., Denetle. P., Auwerx. J., and Staels. B. Regulation of rat liver apolipoprotein A-l. apolipoprotein A-ll. and acyl-CoA oxidasc gene expression by fibratcs and dietary faty acids. Eur. J. Biochem., 232: 179-187. 1985.
47. Staels. B., Van Toi, A., Skrctling. G., and Auwcrx. J. Lecithin:cholesterol acyltransferasc gene expression is regulated in a tissue-selective manner by fibratcs. J. Lipid. Res., 33: 727-735. 1992.
48. Bovard-Houppcrmans. S., Ochoa, A., Fruchart, J.C., and Zakin, M.M Fenofibric acid modulates the human apolipoprotein A-IV gene expression in HepG2 cells. Biochem Biophys. Res. Commun., 198: 764-769. 1994.
49. Schmidt. A., Endo, N., Rutledge, S.J., Vogel, R., Shinar. D., and Rodan, G.A. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome prolifcrator and fatty acids. Mol. Endocrinol., 6: 1634-1641. 1992.
50. Mellies, M.J., Stein. E.A. Khoury. P., Lamkin. G., and Glueck. C.J. Effects of fcnofibrate on lipids, linoproteins and apolipoproteins in 33 subjects with primary hypercholesterolaemia. Atherosclerosis 78: 167-182. 1989.
51. Vu-Dac. N., Schoonjans. K., Laine. B., Fruchart, J.C., Auwerx. J., and Staels. B. Negative regulation of the human apolipoprotein A-l promoter by fibratcs can be attenuated by the interaction of the peroxisome prolifcrator-activated receptor with its response clement. J. Biol. Chem., 269: 31012-31018. 1994.
52. Reddy, J.K., Azarnoff, D.L., and H ignite. C.E. Hypolipidaemic hepatic peroxisome p rol iterators form a novel class of chemical carcinogens. Nature. 283: 397-398. 1980.
53. Reddy, J.K., Scarpelli, D.G., Subbarao, V., and Lalwani, N.D. Chemical carcinogens without mutagenic activity: peroxisome proliferators as a prototype. Toxicol. Pathol., II: 172-180, 1983.
54. Reddy, J.K. and Lalwani, N.D. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol., 12: 1-58, 1993.
55. Reddy, J.K. and Rao, M.S. Peroxisome proliferators and cancer: mechanisms and implications. Trends. Pharmacol. Sei., 7: 631-636, 1996.
56. Rao, M.S., Kokkinakis, D.M., Subbarao, V., and Reddy, J.K. Peroxisome proliferator-induced hepatocarcinogenesis: levels of activating and detoxifying enzymes in hepatocellular carcinomas induced by ciprofibrate. Carcinogenesis, 8: 19-23, 1987.
57. Warren, J.R., Simmon, V.F., and Reddy, J.K. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays. Cancer Res., 40: 36-41. 1980.
58. Glauert, H.P., Reddy, J.K., Kennan, W.S., Sattler, G.L., Rao, VS., and Pilot, H.C. Effect of hypolipidemic peroxisome proliferators on unscheduled DNA synthesis in cultured hepatocytes and on mutagenesis in Salmonella. Cancer Lett., 24: 147-156, 1984.
59. Yoshikawa, K., Tanaka, A., Yamaha. T., and Kurata. H. Mutagenicity study of nine monoalkyl phthalates and a dialkyl phthalate using Salmonella typhimurium and Escherichia coli. Food. Chem. Toxicol., 21: 221-223. 1983.
60. Agarwal, D.K., Lawrence, W.H., Nunez, L.J., and Autian. J. Mutagenicity evaluation of phthalic acid esters and metabolites in Salmonella typhimurium cultures. J. Toxicol. Environ. Health. 16: 61-69. 1985.
61. Cattley, R.C., Smith-Oliver, T., Butterworth, B.E., and Popp, J.A. Failure of the peroxisome proliferator WY-14.643 to induce unscheduled DNA synthesis in rat hepatocytes following in vivo treatment. Carcinogenesis, 9: 1179-1183. 1988.
62. Williams, G.M., Maruyama. H., and Tanaka. T. Lack of rapid initiating, promoting or sequential syncarcinogenic effects of di(2-ethylhexyl)phthalate in rat liver carcinogenesis. Carcinogenesis. 8: 875-880, 1987.
63. Cattley, R.C., Marsman, D.S., and Popp, J.A. Failure of the peroxisome proliferator WY-14.643 to initiate growth-selectable foci in rat liver. Toxicology., 56: 1-7, 1989.
64. Conway, J.G., Tomaszewski, K.E., Olson, M.J., Cattley, R.C., Marsman, D.S., and Popp. J.A. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthslate and Wy-14,643. Carcinogenesis, 10: 513-519. 1989.
65. Marsman, D.S., Goldsworthy, T.L., and Popp. J.A. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14.643 and ctofibric acid. Carcinogenesis, 13: 1011-1017. 1992.
66. Kasai. H., Okada. Y, Nishimura, S., Rao, M.S., and Reddy. J.K. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res., 49: 2603-2605. 1989.
67. Takagi, A., Sai, K., Umemura. T., Hasegawa, R., and Kurokawa, Y. Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators: di(2-ethylhexyl) phthalate. aluminium clofibrate and simfibrate. Cancer Lett., 53: 33-38, 1990.
68. Hegi, M.E., Ulrich. D., Sagelsdorff, P., Richter. C., and Lut., W.K. No measurable increase in thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with nafenopin or choline-devoid lowmethionine diet. Mutat. Res., 238: 325-329, 1990.
69. Cattley, R.C. and Glover, S.E. Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization. Carcinogenesis. 14: 2495-2499. 1993.
70. Chu. S., Huang, Q., Alvares, K., Yeldandi, A.V., Rao, M.S., and Reddy, J.K. Transformation of mammalian cells by overexpressing H,O,-generating peroxisomal fatty acyl-CoA oxidase. Proc. Natl. Acad. Sei. USA. 92: 7080-7084.1995.
71. Mikalsen, S.O., Holen, L., and Sanner, T. Morphological transformation and catalase activity of Syrian hamster embryo cells treated with hepatic peroxisome proliferators, TPA and nickel sulphate. Cell Biol. Toxicol., 6: 1-13, 1990.
72. Tsutsui, T., Watanabe, E., and Barrett. J.C. Ability of peroxisome proliferators to induce cell transformation, chromosome aberrations and peroxisome proliferation in cultured Syrian hamster embryo cells. Carcinogenesis. 14:611-618. 1993.
73. Cattley, R.C., Marsman, D.S., and Popp, J.A. Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14.643 in rat liver. Carcinogenesis (in press), 1996.
74. Farber, E. Experimental induction of hepatocellular carcinoma as a paradigm for carcinogenesis. Clin. Physiol. Biochem., 5: 152-159, 1987.
75. Moody, D.E., Rao, M.S., and Reddy, J.K. Mitogenic effect in mouse liver induced by a hypolipidemic drug, nafenopin. Virchows Arch. B. Cell Pathol., 23: 291-296. 1977.
76. Marsman, D.S., Catlley, R.C., Conway, J.G., and Popp, J.A. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyllphthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14.643) in rats. Cancer Res., 48: 6739-6744, 1988.
77. Reddy, J.K., Reddy, M.K., Usman, M.I., Lalwani, N.D., and Rao, M.S. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug. Environ. Health Perspect., 65: 317-327. 1986.
78. Tomaszewski, K.E., Agarvval, D.K., and Melnick, R.L. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3FI mice to hepatic peroxisome proliferators. Carcinogenesis. 7: 1871-1876, 1986.
79. Barren. J.C. Mechanisms for species differences in receptor-mediated carcinogenesis. Mutat. Res., 333: 189-202, 1995.
80. Bayly, A.C., Roberts, R.A., and Dive, C. Suppression of liver cell apoptosis in vitro by the non-gcnutoxic hepatocardnogen and peroxisome proliferator nafenopin. J. Cell Biol., 125: 197-203, 1994.
81. Roberts, R.A., Soames, A.R., Gill, J.H., James, N.H., and Wheeldon. H.B. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis. but in different hepatocyte populations. Carcinogenesis, 16: 1693-1698, 1995.
82. James, N.H. and Roberts, R.A. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes. Carcinogenesis, 15: 2687-2694, 1994.
83. Lake, B.C., Evans, J.G., Gray, T.J., Korosi, S.A., and North, C.J. Comparative studies on nafenopin-induccd hepatic peroxisome proliferation in the rat. Syrian hamster, guinea pig. and marmoset. Toxicol. Appl. Pharmacol., 99: 148-160, 1989.
84. Reddy, J.K. and Rao, M.S. Peroxisome proliferation and hepatocarcinogenesis. 1992.
85. Varanasi. U., Chu, R., Huang, Q., Castellon, R., Yeldandi, A.V., and Reddy. J.K. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene. J. Biol. Chem., 271: 2147-2155, 1996.
86. Hardwick, J.P., Song, B.J., Huberman, E., and Gonzalez, F.J. Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid omega-hydroxylase (cytochrome P-450LA omega). Identification of a new cytochrome P-450 gene family. J. Biol. Chem., 262: 801-810. 1987.
87. Lee, S.S., Pineau, T., Drago, J., Lee, E.J., Owens, J.W., Kroetz, D.L., Fernandez-Salguero, P.M., Westphal, H., and Gonzalez. F.J. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiolropic effects of peroxisomc proliferators. Mol. Cell Biol., 15: 3012-3022, 1995.
88. Gonzalez, F.J., Fernandez-Salguero, P., Lee, S.S., Pineau, T., and Ward, J.M. Xenobiotic receptor knockout mice. Toxicol. Lett., 82-83: 117-121. 1995.
89. Lemberger. T., Saladin, R., Vazquez, M., Assimacopoulos, F., Staels. B., Desvergne, B., Wahli. W., and Auwerx, J. Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J. Biol. Chem., 271: 1764-1769. 1996.
90. Issemann, I. and Green, S. Cloning of novel members of the steroid hormone receptor superfamily. J. Steroid. Biochem. Mol. Biol., 40: 263-269, 1991.
91. Yamada, J., Sakuma, M., Ikeda, T., and Suga, T. Activation of dehydroepiandrosterone as a peroxisome proliferator by sulfate conjugation. Arch. Biochem. Biophys., 313: 379-381. 1994.
92. Yamada. J., Sakuma, M., Ikeda, T., Fukuda, K., and Suga, T. Characteristics of dehydroepiandrosterone as a peroxisome proliferator. Biochim. Biophys. Acta, 1092: 233-243, 1991.
93. Frenkel, R.A., Slaughter, C.A., Orth, K., Moomaw, C.R., Hicks, S.H., Snyder, J.M., Bennett, M., Prough. R.A., Putnam, R.S., and Milewich, L. Peroxisome proliferation and induction of peroxisomal enzymes m mouse and rat liver by dehydroepiandrosterone feeding. J. Steroid. Biochem., 35: 333-342, 1990.
94. Hayashi, F., Tamura, H., Yamada, J., Kasai, H., and Suga, T. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats. Carcinogenesis, 15: 2215-2219, 1994.
95. Shibata, M., Hasegawa, R., Imaida, K., Hagiwara, A., Ogawa, K., Hirosc, M., Ito, N., and Shirai, T. Chemoprevention by dehydroepiandrosterone and indomethacin in a rat multiorgan carcinogenesis model. Cancer Res., 55: 4870-4874, 1995.
96. Gordon, G.B., Helzlsouer, K.J., and Comstock, G.W. Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer. Cancer Res., 51: 1366-1369, 1991.
97. Waxman, D.J. Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator. Mol. Pharmacol., 50: 67-74. 1996.
98. Ledwith, B.J., Johnson, T.E., Wagner, L.K., Pauley, C.J., Manam, S., Galloway, S.M., and Michels. W.W. Growth regulation by peroxisome proliferators:opposing activities in early and late Gl. Cancer Res., 56: 3257-3264. 1996.
99. Schulz. S. and Nyce. J.W. Inhibition of protein farnesyltransferase: a possible mechanism of tumor prevention by dehydroepiandrosterone sulfate [published erratum appears in Carcinogenesis 1995 Jan;16( 11:149] [retracted by Nyce JW. In: Carcinogenesis 1995 May; 16(5): 1257]. Carcinogenesis. 15: 2649-2652. 1994.
100. Nyce. J.W. Inhibition of protein farnesyltransferase: a possible mechanism of tumor prevention for dehydroepiandrosterone sulfate [retraction of Schulz S. Nyce JW. In: Carcinogenesis 1994 Nov: 15(11 ):2649-52]. Carcinogenesis. 16: 1257. 1995.
101. Peters, J.M., Zhou, Y.C., Ram, P.A., Lee. S.S.T., Gonzalez, F.J., and Waxman. D.J. Peroxisome pro I iterator-activated receptor alpha required for gene induction by dchydrocpiandrostcrone-3-heta-sulfatc. Mol. Pharmacol., 50: 67-74. 1996.
102. Thibault, A., Cooper, M.R., Figg, W.D., Vcnzon, D.J., Sartor, A.O., Tompkins, A.C., Weinbcrger, M.S., Headlee, D.J., McCall, N .A., and Samid. D. A phase I and pharmacokinetic study of intravenous phenylaceiate in patients with cancer. Cancer Res., 54: 1690-1694. 1994.
103. Samid. D., Shack. S., and Mycrs. CE. Selective growth arrest and phcnotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetatc. J. Clin. Invest., 91: 2288-2295. 1993.
104. Samid. D., Ram. Z., Hudgins, W.R., Shack. S., Liu. L. Walbridgc. S., Oldfield. EH. and Myers. C.F. Selective activity of phenylaceiate against malignant gliomas: resemblance to fetal brain damage in phenylkctonuriii. Cancer Res., 54: X9I-M95. 1994.
105. Liu. L., Shack. S., Stctlcr-Stevenson, W.G., Hudgins, W.R., and Samid. D. Differentiation of cultured human melanoma cells induced by the aromatic fatty acids phenylacetatc and phenylbutyratc J. Im est. Dcrmalol., 103: 335-340. 1994.
106. Stockhammer. G., Manley, G.T., Johnson. R . Roscnblum, M.K., Samid. D., and Lieherman. F.S. Inhibition of proliferation and induction of differentiation in mcdulloblastomu- and astrocytoma-derived cell lines with phenylacetate. J. Neurosurg., 83: 672-681. 1995.
107. Lipschutz, J.H., Samid. D., and Cunha. G.R. Phenylacetatc is an inhibitor of prostatic growth and development in organ culture. J. Urol., 155: 1762-1770. 1996.
108. Pineau. T., Hudgins, W.R., Liu. L., Chen, L.C., Shcr. T., Gonzalez, F.J., and Samid. D. Activation of a human peroxisome prolifcrator-activaled receptor by the antitumor agent phcnylacetate and its analogs. Biochem. Pharmacol., 52: 659-467. 1996.
109. Forman, B.M., Tontonoz. P., Chen. J., Brun, R.P., Spiegelman, B.M., and Evans. R.M. 15-Deoxy-delta 12. 14-prostaglandin J2 is a ligatul for the adipocyte determination factor PPAR gamma. Cell. 83: 803-812. 1995.
110. Yu. K., Bayona. VV., Kallen, C.B., Harding, H.P., Ravera, C.P., McMahon. G., Brown. M., and Lazar. M.A. Differential activation of peroxisome prolifcrator-activatcd receptors by cicosanotds. J. Biol. Chcm . 270: 23975-23983. 1995.